U.S. Markets open in 3 hrs, 3 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,344.84 | 34.92 | 0.34% |
| NASDAQ | 2,144.60 | 6.16 | 0.29% |
| S&P 500 | 1,095.63 | 4.14 | 0.38% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 02/08/2010 * | 18:00 | Q4 2009 Vanda Pharmaceuticals, Inc. Earnings Release |  |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 11/02/2009 | Q3 2009 Vanda Pharmaceuticals, Inc. Earnings Conference Call |  |
Download($) |
| 11/02/2009 | Q3 2009 Vanda Pharmaceuticals, Inc. Earnings Release | — | — |
| 10/13/2009 | Vanda Pharmaceuticals, Inc. Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia Conference Call | |
Download($) |
| 08/10/2009 | Q2 2009 Vanda Pharmaceuticals, Inc. Earnings Conference Call | |
Download($) |
| 08/10/2009 | Q2 2009 Vanda Pharmaceuticals, Inc. Earnings Release | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts